Infliximab for Injection
Efficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
The first infliximab biosimilar marketed in China
Infliximab for Injection (Reminton), a recombinant anti-TNF-alpha chimeric monoclonal antibody, was approved for marketing by the National Medical Products Administration (NMPA) on July 14, 2021. It is the first infliximab biosimilar marketed in China. Taking advantage of CHO cell expression system, Remin_x005f ton has been proved with good efficacy, better safety, and lower immunogenicity in clinical studies.
Indications:
Crohn's disease in adults and children over 6 years of age, stulizing Crohn's disease,
ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, and psoriasis.
Recommended reading
Related products
-
Quick View
Fusce congue cursus metus
$88.00Add to cartNulla feugiat felis tempor sem finibus egestas. Maecenas est nunc, faucibus in tristique nec, ornare et tortor. Mauris maximus lectus vel metus finibus, eget ullamcorper leo auctor. Donec at interdum nibh, in blandit massa. Nam pulvinar mollis quam
-
Quick View
Donec ullamcorper turpis
$45.00Add to cartAliquam porttitor mattis erat, a eleifend lorem tempor ut. Donec erat lacus, ultricies at dolor sed, accumsan sollicitudin libero. Praesent pellentesque sed odio et fringilla. Donec a semper metus. Nulla mollis sodales sem vitae congue. Donec laoreet nunc sed metus pretium volutpat. Nunc quis feugiat elit.
-
Quick View
Mauris elit magna, aliquet
$50.00Add to cartFusce sagittis tellus eget ante gravida euismod. Mauris interdum, neque eu hendrerit aliquet, diam nisi fringilla nisi, at convallis ante velit sed erat. Vestibulum mollis lorem ut molestie pharetra. Sed pretium quam lacinia, placerat urna a, tincidunt massa. Mauris elit magna, aliquet blandit mauris eu
-
Quick View
Aenean non pellentesque mauris
Original price was: $68.00.$55.00Current price is: $55.00.Add to cartNullam porttitor pharetra ullamcorper. Praesent varius erat vitae nibh laoreet cursus. Donec suscipit gravida viverra. Suspendisse consectetur ipsum augue, a varius enim tempus a. Phasellus id nibh arcu. Curabitur rutrum vehicula mi id congue. Phasellus vitae leo sodales, pretium turpis non, efficitur eros. Donec fermentum at nisi suscipit vulputate.
Reviews
There are no reviews yet.